Onyx Shares Boom as FDA Panel Backs Blood CA Med - June 21, 2012

Having trouble viewing this email? View in Browser.

Thursday, June 21, 2012  |   |   |   |  Myriad RBM's Strategic Biomarker Services can provide solutions to help discover and validate biomarker patterns for use in the following clinical trial and companion diagnostic applications: • Identifying responders versus non-responders • Expanding indications for approved drugs/Drug re-tasking • Predicting drug toxicity • Therapeutic monitoring • Pharmacodynamics Please click here for more information. •  Onyx Pharmaceuticals, Inc. (ONXX) Shares Boom as FDA Panel Backs Blood CA Med More... •  Celgene Corporation (CELG) Revlimid Growth Plans Stopped Dead; Stock Plummets -7.53(11.20%) @ 1:03PM EDT More... •  FDA Says Pozen, Inc. (POZN) Ulcer Drug May Need More Data, Shares Plunge More... •  FDA Panel Rejects Sanofi (France) (SAN.PA) Clotting Drug for Chemo Patients More... •  Gentium S.p.A. Submits Day 180 Response to List of Outstanding Issues Received From the EMA's CHMP for Defibrotide MAA More... More BLA/NDA/ANDA News More IND News More MAA News •  Pfizer Inc. (PFE)'s Lyrica Gains U.S. Approval for Spinal Pain More... More Drug Approval News •  Chelsea Therapeutics, Inc. (CHTP) Release: Combined Northera™ (droxidopa) Data From Two Phase 3 Trials Confirm Symptom Improvement in Patients With Neurogenic OH More... •  Iroko Pharmaceuticals Release: Novel, Submicron Particle, Lower-Dose Diclofenac Demonstrated Relief of Acute Pain in Phase 3 Study More... •  StemCells Inc. (STEM) Initiates Phase I/II Clinical Trial in Dry Age-Related Macular Degeneration More... •  AEterna Zentaris (AEZS): Phase 1 Results Show Perifosine's Activity Against Neuroblastoma More... •  Cleveland Biolabs Inc. (CBLI) and Incuron Announce Results of Studies of CBL0137 in Animal Models of Neuroblastoma More... More Phase III News More Phase II News More Phase I News More Pre-Clinical News More Post-Approval News Post Master's Graduate Certificate in Sequence Analysis and Genomics This new certificate is targeted at scientists who already have grounding in biochemistry, molecular biology and cell biology and but need the bioinformatics skills to design experiments and analyze data. The program introduces students to the foundations of bioinformatics through the core bioinformatics courses and then the students take upper level courses that are required for understanding and performing sequence and genomic analysis. This program will be offered online and onsite. Please click here for more information. •  Robust Octogenarians' Genes Seen Holding Secrets to Aging, Scripps Translational Science Institute Study More... •  What Motivates Generosity? Researchers Study Muslims and Catholics, Arizona State University Study More... •  Healthy Muscle Mass Linked to Healthy Bones, But There are Gender Differences, Mayo Clinic Study More... •  Adolescents Who Have More Than 4 Meals a Day are Thinner, Spanish National Research Council Study More... •  American Heart Association Release:Three Therapies May Reverse Action of New Blood-Thinning Drug More... More General Clinical Research News • Bio NC (Research Triangle Park, North Carolina) Sequenom Inc. Clinical Laboratory Associate Director Review data, approve and sign-out results for high complexity genetic and molecular laboratory developed tests on a daily basis and act as a clinical consultant for the lab. Report laboratory test results for all test methods approved by CAP, NC, NY, CA and CLIA from pre-analytical, analytical and post-analytical testing; interprets reports and patient results to ordering physicians • BioMidwest (Indianapolis, Indiana) Eli Lilly and Company Associate Consultant - Clinical Trial Management Plans and executes trial-level project management activities for assigned studies including trial-level timelines, risk assessment, mitigation plans, and other aspects of trial-level project management (e.g. budget, grants, metrics). • Biotech Beach (Santa Barbara, California) Allergan Inc. Senior Clinical Safety Scientist Responsible for the proactive safety strategy and all medical safety aspects of a medical device including medical risk management for assigned development of marketed products and clinical studies. • Biotech Bay (South San Francisco, California) Johnson & Johnson Family of Companies Director, Clinical Operations Provides input to clinical development plans and manages their implementation in conformance to all relevant laws, regulations, guidelines, policies and procedures through the team of Clinical Operations staff. • Genetown (Cambridge, Massachusetts) Novartis Institutes for BioMedical Research, Inc. Clinical Data Analyst Will provide real-time data visualization and analysis for clinical studies; facilitate data integration and 'best practice' visualization within clinical trials; propose and support the imple-mentation of new technologies that can deliver enhanced clinical trials and more efficient internal processes. • Get Noticed! Add your resume to the BioSpace Career Center! • See more than 5,000 job postings in the BioSpace Career Center! Job seekers can spend days with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in various regions across the U.S. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services •  TherapeuticsMD, Inc. Files for Two Additional Patents on Prescription Products for Treatment of Menopausal Symptoms & Related Conditions More... More Patent News •  Centers for Disease Control and Prevention (CDC) Recommends Pfizer Inc. (PFE)'s Prevnar for Immune-Weakened Adults More... •  European Medicines Agency Clears Roche (RHHBY) Cancer Drug MabThera More... •  Cell Therapeutics, Inc. (CTIC) Readies Commercial Launch of Pixuvri® in EU; Re-Alignment of Resources and Portfolio Priorities Reduces Burn Rate by More Than 30% More... •  Nouveau Life Pharmaceuticals (NOUV) Releases Azul Instant™ More... More Drug Product News Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set. Request Now! Biomarkers in Late Stage Clinical Trials • Quantify and analyze revenues of late stage biomarker technology and services in North America, Europe, Asia and the Rest of the World. • Identify the key market drivers and resistors of the biomarker market and evaluate the growth potential of emerging technologies. • Assess biomarker activity at leading companies, including Abbott, AZ, BMS, Eli Lilly, GSK, Merck & Co, Novartis, Pfizer, Roche and Sanofi-Aventis. Click Here for More Information. Hot Company Roche 340 Kingsland Street Nutley, New Jersey 07110 U.S.A. Phone: 973-235-5000 Fax: 973-235-7605 For more than 100 years, Roche has built a legacy of innovation, decade by decade, discovery by discovery. We continue to focus on developing new, innovative and clinically differentiated medicines in five key areas: central nervous system, inflammation, metabolism, oncology, and virology. More Company Profiles Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship ClinicaSpace 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 ClinicaSpace 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the ClinicaSpace News Beat Team. Editor & Publisher: Lana Ho Editorial & Production Staff: Maysa Darwish, Tammy Liu ClinicaSpace.com - Clinical Trials. Clinical Research. Community. • ClinicaSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 ClinicaSpace http://www.clinicaspace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.